|
顯示項目 2259941-2259965 / 2349140 (共93966頁)
<< < 90393 90394 90395 90396 90397 90398 90399 90400 90401 90402 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2022-02-04 |
Recent advances and biomedical applications of peptide-integrated conducting polymers
|
Wang, CC;Wei, SC;Luo, SC |
| 輔英科技大學 |
2022-02-04 |
Heat-Killed Lacticaseibacillus paracasei GMNL-653 Exerts Antiosteoporotic Effects by Restoring the Gut microbiota Dysbiosis in Ovariectomized Mice
|
Jhong, Jhih-Hua;Tsai, Wan-Hua;Yang, Li-Chan;Chou, Chia-Hsuan;Lee, Tzong-Yi;Yeh, Yao-Tsung;Huang, Cheng-Hsieh;Luo, Yueh-Hsia |
| 國家衛生研究院 |
2022-02-05 |
Low concentrations of 4-ABP promote liver carcinogenesis in human liver cells and a zebrafish model
|
Lin, HD;Tseng, YK;Yuh, CH;Chen, SC |
| 國家衛生研究院 |
2022-02-05 |
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design
|
Yeh, TK;Song, JS;Chang, PW;Yu, JC;Chang, CH;Liao, FY;Tien, YW;Kuppusamy, R;Li, AS;Chen, CH;Chen, CW;Lin, LM;Chang, HH;Huang, CH;Yao, JY;Wu, MH;Peng, YH;Hsueh, CC;Hsiao, WC;Chen, PH;Lin, CY;Hsieh, SH;Shih, C;Hung, MS;Wu, SY;Kuo, CC;Ueng, SH |
| 淡江大學 |
2022-02-05 |
Facile formation of symmetric microporous PVDF membranes via vapor-induced phase separation of metastable dopes
|
Su, Jenn Fang;Beltsios, Konstantinos G.;Li, Ping-Hong;Cheng, Liao-Ping |
| 淡江大學 |
2022-02-05 |
Facile formation of symmetric microporous PVDF membranes via vapor-induced phase separation of metastable dopes
|
Su, Jenn Fang;Beltsios, Konstantinos G.;Li, Ping-Hong;Cheng, Liao-Ping |
| 國家衛生研究院 |
2022-02-05 |
Local cytotoxic effects in cobra envenoming: A pilot study
|
Lin, JH;Sung, WC;Mu, HW;Hung, DZ |
| 國立成功大學 |
2022-02-05 |
Method for detecting mechanical and magnetic features with nanoscale resolution
|
陳宜君Chen, Yi-Chun;Liou, Yi-De;Weng, Yi-Hsin |
| 國家衛生研究院 |
2022-02-06 |
Metabolic reprogramming in response to alterations of mitochondrial DNA and mitochondrial dysfunction in gastric adenocarcinoma
|
Chang, TC;Lee, HT;Pan, SC;Cho, SH;Cheng, CH;Ou, LH;Lin, CI;Lin, CS;Wei, YH |
| 國家衛生研究院 |
2022-02-06 |
Statins reduce hepatocellular carcinoma risk in patients with chronic kidney disease and end-stage renal disease: A 17-year longitudinal study
|
Sung, FC;Yeh, YT;Muo, CH;Hsu, CC;Tsai, WC;Hsu, YH |
| 國立臺中教育大學 |
2022-02-07 |
傳統漆藝蒔繪在漆畫的運用－花漾・物語黃國樑創作論述
|
黃國樑; Huang, Kuo-Liang |
| 淡江大學 |
2022-02-07 |
Using Image Recognition to Process Unbalanced Data in Genetic Diseases From Biobanks
|
Hsieh, Ai-Ru;Li, Yi-Mei Aimee |
| 國家衛生研究院 |
2022-02-07 |
The influence of diabetes mellitus on the risks of end-stage kidney disease and mortality after liver transplantation
|
Lee, CY;Wu, MY;Chan, HC;Chen, TT;Hsu, LY;Wu, MS;Cherng, YG |
| 國立成功大學 |
2022-02-07 |
劇烈天氣系統與藍色噴流形成之關聯性研究
|
蘇漢宗 |
| 國家衛生研究院 |
2022-02-07 |
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; CHIH-HUNG HSU; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Chen B.-B.; Lin Z.-Z.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma
|
Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Solving the deficit of cancer pain management skills by education programs
|
Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; Lu L.-C.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:06Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; Hsu C.; CHIH-HUNG HSU; Yang M.-H.; Chao Y. |
顯示項目 2259941-2259965 / 2349140 (共93966頁)
<< < 90393 90394 90395 90396 90397 90398 90399 90400 90401 90402 > >>
每頁顯示[10|25|50]項目
|
